公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2017 | CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis | Ayhan A.; Kuhn E.; Wu R.-C.; Ogawa H.; Bahadirli-Talbott A.; TSUI-LIEN MAO ; Sugimura H.; Shih I.-M.; Wang T.-L. | Modern Pathology | 41 | 40 | |
2017 | Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial | Ridker P.M.; MacFadyen J.G.; Thuren T.; Everett B.M.; Libby P.; Glynn R.J.; Lorenzatti A.; Krum H.; Varigos J.; Siostrzonek P.; Sinnaeve P.; Fonseca F.; Nicolau J.; Gotcheva N.; Genest J.; Yong H.; Urina-Triana M.; Milicic D.; Cifkova R.; Vettus R.; Koenig W.; Anker S.D.; Manolis A.J.; Wyss F.; Forster T.; Sigurdsson A.; Pais P.; Fucili A.; Ogawa H.; Shimokawa H.; Veze I.; Petrauskiene B.; Salvador L.; Kastelein J.; Cornel J.H.; Klemsdal T.O.; Medina F.; Budaj A.; Vida-Simiti L.; Kobalava Z.; Otasevic P.; Pella D.; Lainscak M.; Seung K.-B.; Commerford P.; Dellborg M.; Donath M.; HWANG, JUEY-JEN ; Kultursay H.; Flather M.; Ballantyne C.; Bilazarian S.; Chang W.; East C.; Forgosh L.; Harris B.; Ligueros M.; Bohula E.; Charmarthi B.; Cheng S.; Chou S.; Danik J.; McMahon G.; Maron B.; Ning M.; Olenchock B.; Pande R.; Perlstein T.; Pradhan A.; Rost N.; Singhal A.; Taqueti V.; Wei N.; Burris H.; Cioffi A.; Dalseg A.M.; Ghosh N.; Gralow J.; Mayer T.; Rugo H.; Fowler V.; Limaye A.P.; Cosgrove S.; Levine D.; Lopes R.; Scott J.; Hilkert R.; Tamesby G.; Mickel C.; Manning B.; Woelcke J.; Tan M.; Manfreda S.; Ponce T.; Kam J.; Saini R.; Banker K.; Salko T.; Nandy P.; Tawfik R.; O'Neil G.; Manne S.; Jirvankar P.; Lal S.; Nema D.; Jose J.; Collins R.; Bailey K.; Blumenthal R.; Colhoun H.; Gersh B. | The Lancet | 879 | 785 | |
2015 | Immunohistochemical study of endometrial high-grade endometrioid carcinoma with or without a concurrent low-grade component: Implications for pathogenetic and survival differences | TSUI-LIEN MAO ; Ayhan A.; KUAN-TING KUO ; Lin M.-C.; LI-HUI TSENG ; Ogawa H. | Histopathology | 4 | 4 | |
2015 | Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors | Ayhan A.; TSUI-LIEN MAO ; Suryo Rahmanto Y.; Zeppernick F.; Ogawa H.; Wu R.-C.; Wang T.-L.; Shih I.-M. | Journal of Pathology: Clinical Research | 31 | 0 | |
2012 | Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma | Ayhan A.; TSUI-LIEN MAO ; Seckin T.; Wu C.-H.; Guan B.; Ogawa H.; Futagami M.; Mizukami H.; Yokoyama Y.; Kurman R.J.; Shih I.-M. | International Journal of Gynecological Cancer | 135 | 120 | |
2018 | Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial | Ridker P.M.; MacFadyen J.G.; Everett B.M.; Libby P.; Thuren T.; Glynn R.J.; Kastelein J.; Koenig W.; Genest J.; Lorenzatti A.; Varigos J.; Siostrzonek P.; Sinnaeve P.; Fonseca F.; Nicolau J.; Gotcheva N.; Yong H.; Urina-Triana M.; Milicic D.; Cifkova R.; Vettus R.; Anker S.D.; Manolis A.J.; Wyss F.; Forster T.; Sigurdsson A.; Pais P.; Fucili A.; Ogawa H.; Shimokawa H.; Veze I.; Petrauskiene B.; Salvador L.; Cornel J.H.; Klemsdal T.O.; Medina F.; Budaj A.; Vida-Simiti L.; Kobalava Z.; Otasevic P.; Pella D.; Lainscak M.; Seung K.-B.; Commerford P.; Dellborg M.; Donath M.; HWANG, JUEY-JEN ; Kultursay H.; Flather M.; Ballantyne C.; Bilazarian S.; Chang W.; East C.; Forgosh L.; Harris B.; Ligueros M.; CANTOS Trial Group | The Lancet | 606 | 515 | |
2019 | Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key? | Fruchart J.-C.; Santos R.D.; Yamashita S.; Libby P.; Aikawa M.; Plutzky J.; Pradhan A.; Ridker P.; Aguilar-Salinas C.; Al Rasadi K.; Amarenco P.; Barter P.J.; Ceska R.; Corsini A.; Ruscica M.; Despr?s J.-P.; Duriez P.; Eckel R.H.; Ezhov M.V.; Farnier M.; Ginsberg H.N.; Hermans M.P.; Ishibashi S.; Karpe F.; Kodama T.; Koenig W.; Krempf M.; Lim S.; Lorenzatti A.J.; McPherson R.; Nu?ez-Cortes J.M.; Nordestgaard B.G.; Ogawa H.; Packard C.J.; Ponte-Negretti C.I.; Reiner ?.; Sadikot S.; Shimano H.; Sritara P.; Stock J.K.; TA-CHEN SU ; Susekov A.V.; Tartar A.; Taskinen M.-R.; Tenenbaum A.; Tokg?zo?lu L.S.; Tomlinson B.; Tybj?rg-Hansen A.; Valensi P.; Vrabl?k M.; Wahli W.; Watts G.F.; Yokote K.; Zambon A.; International Atherosclerosis Society/R3i Foundation Consensus Panel | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 4 | 3 | |
2019 | The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: Conceptual framework and therapeutic potential | Fruchart J.-C.; Santos R.D.; Aguilar-Salinas C.; Aikawa M.; Al Rasadi K.; Amarenco P.; Barter P.J.; Ceska R.; Corsini A.; Despr?s J.-P.; Duriez P.; Eckel R.H.; Ezhov M.V.; Farnier M.; Ginsberg H.N.; Hermans M.P.; Ishibashi S.; Karpe F.; Kodama T.; Koenig W.; Krempf M.; Lim S.; Lorenzatti A.J.; McPherson R.; Nu?ez-Cortes J.M.; Nordestgaard B?.G.; Ogawa H.; Packard C.J.; Plutzky J.; Ponte-Negretti C.I.; Pradhan A.; Ray K.K.; Reiner Z.; Ridker P.M.; Ruscica M.; Sadikot S.; Shimano H.; Sritara P.; Stock J.K.; TA-CHEN SU ; Susekov A.V.; Tartar A.; Taskinen M.-R.; Tenenbaum A.; Tokg?zo?lu L.S.; Tomlinson B.; Tybj?rg-Hansen A.; Valensi P.; Vrabl?k M.; Wahli W.; Watts G.F.; Yamashita S.; Yokote K.; Zambon A.; Libby P. | Cardiovascular Diabetology | 97 | 85 |